| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de48b689b67bf3e1f33ccae4239e6150
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d75d1a4caed60a9316608ed9c231546c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6702b1bad9eed1a024aa9040f9fd6602 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2012-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54fb9243b791a2c468eeca3998f005e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8daa9cfe73a2b2f25ac83908799a0782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde4854e38221d9a6dd508d3af65215d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d546759f870dc8fabf344d9a2cbd97b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbc6aae3c9b2106a555b9b8832335616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c67f22a4289230b91af2d31bfcd5cb5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eda61ad0c32b70290ca2662d19371f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60bd43e7c8fc1d8cfbc90bcd81f96c06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f95b259da8ece8acdc02421bb54a7012 |
| publicationDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2013253848-A |
| titleOfInvention |
Acute coronary syndrome marker and its use |
| abstract |
An object of the present invention is to provide a method for examining a biological sample derived from a subject for determining the pathological condition or risk of developing acute coronary syndrome, and a diagnostic agent used therefor. The present invention relates to a method for examining plasma and / or serum of a subject for determining the pathology or risk of developing acute coronary syndromes, and (1) soluble in plasma and / or serum of the subject Measuring the amyloid β precursor protein (sAPP) 770 level; and (2) correlating the sAPP770 level in plasma and / or serum measured in (1) with the pathological condition or risk of developing acute coronary syndrome Including a method. [Selection figure] None |
| priorityDate |
2012-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |